The Federal Government has accepted the recommendations of the Clinical Trials Action Group report and will introduce changes intended to increase pharmaceutical research and development and improve the clinical trials approval process.


The report recommends ways to:

  • make approval processes for clinical trials being conducted in different states and territories more efficient;
  • increase the benefits to the health system that come from e-Health reforms; and
  • encourage more people to be involved in clinical trials.


The Clinical Trials Action Group, an initiative of the Pharmaceutical Industry Working Group, was was co-chaired by Richard Marles MP, then Parliamentary Secretary for Innovation and Industry, and Mark Butler MP, then Parliamentary Secretary for Health. It was advised by around 50 people including clinicians, researchers, companies and state, territory and federal government officials.  More than 50 submissions were received from interested organisations and the public.

The report is available at